10 Results for "

maximal electroshock (MES)

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "maximal electroshock (MES)" in MCE Product Catalog:

Cat. No.: HY-172431
CAS No.: 2376397-93-0
Synonyms: BHV-7000
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Opakalim (BHV-7000) is a selective Kv7.2/7.3 potassium channels activator with an EC50 of 0.6 μM. Opakalim shows minimal GABAA receptor activation and exhibits potent anti-seizure efficacy in the maximal electroshock seizure (MES) model. Opakalim can be used for the study of seizures .
loading...
    loading...
Cat. No.: HY-168773
CAS No.: 2506367-95-7
Target:  

EAAT

Research Areas:  

Neurological Disease

(R)-AS-1 is a selective positive allosteric modulator of the excitatory amino acid transporter 2 (EAAT2), with an EC50 of 11 nM. (R)-AS-1 (at doses of 60 and 90 mg/kg) increases spontaneous locomotor activity in mice. Additionally, it demonstrates anticonvulsant activity in mouse models of seizures induced by maximal electroshock (MES), pentylenetetrazole (PTZ), or electrical stimuli (32 or 44 mA), with ED50s of 66.3, 36.3, 15.6, and 41.6 mg/kg, respectively. (R)-AS-1 can be used in neurological disease research .
loading...
    loading...
Cat. No.: HY-W012481
CAS No.: 631-07-2
Synonyms: Ethylphenylhydantoin; Phenylethyihydantoin; Desmethylmephenytoin
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease

Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-W097106
CAS No.: 60846-91-5
Target:  

Drug Isomer

Research Areas:  

Neurological Disease

(S)-3-N-Cbz-Amino-succinimide (Compound 1d) is an antiepileptic agent that can inhibit pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced tonic convulsions in mice .
loading...
    loading...
Cat. No.: HY-106424
CAS No.: 130403-08-6
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Soretolide is an antiepileptic agent. Soretolide is effective in maximal electroshock-induced seizure (MES) test in rodents. Soretolide inhibits metabolism of Phenytoin (HY-B0448). Soretolide exhibits a good pharmacokinetic character in rats model .
loading...
    loading...
Cat. No.: HY-W012481R
CAS No.: 631-07-2
Synonyms: Ethylphenylhydantoin (Standard); Phenylethyihydantoin (Standard); Desmethylmephenytoin (Standard)
Research Areas:  

Neurological Disease

Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-W012481S
CAS No.: 119458-27-4
Synonyms: Ethylphenylhydantoin-d5; Phenylethyihydantoin-d5; Desmethylmephenytoin-d5
Nirvanol-d5 (Ethylphenylhydantoin-d5) is deuterium labeled Nirvanol (HY-W012481) . Nirvanol (Ethylphenylhydantoin) is a metabolite of Mephenytoin (HY-B1184) that exerts anticonvulsant effects in the maximal electroshock (M.E.S.) seizure model in mice. Nirvanol shows potential for research in epilepsy-related neurological disorders .
loading...
    loading...
Cat. No.: HY-148135
CAS No.: 694466-00-7
Purity:  ≥98.0%
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

CAI/II-IN-6 is an orally active human carbonic anhydrase (hCA) inhibitor. CAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5 and >50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. CAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. CAI/II-IN-6 can be used for the research of epilepsy .
loading...
    loading...
Cat. No.: HY-172887
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Kv7.2/Kv7.3 activator-2 is a BBB-penetrable Kv7.2/7.3 activator (EC50: 0.25 μM). Kv7.2/Kv7.3 activator-2 has good photostability. Kv7.2/Kv7.3 activator-2 has potently antiepileptic effects in maximal electroshock (MES) and sc-pentylenetetrazol (sc-PTZ)-induced acute mice seizure models .
loading...
    loading...
Cat. No.: HY-178016
CAS No.: 3097193-89-7
Target:  

Histamine Receptor

Research Areas:  

Neurological Disease

H3R antagonist 8 is a selective nonimidazole histamine H3 receptor antagonist (IC50 = 0.35 μM). H3R antagonist 8 exhibits hERG channel blockade activity (IC50 = 0.67 μM). H3R antagonist 8 inhibits seizures by antagonizing H3 receptor. H3R antagonist 8 reduces tonic hind limb extension (THLE) in mice in the maximal electroshock seizure (MES) model (ED50 = 20.21 mg/kg) and and shortens pentylenetetrazol (PTZ)-induced total movement distance in AB strain zebrafish larvae. H3R antagonist 8 can be used for the study of epilepsy .
loading...
    loading...